NegativeDouble Blind Clinical Trial2015
The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis
Classification Results
AI Classification
NegativeFine-tuned Classification
Negative